openPR Logo
Press release

Parkinson’s Disease Market Insight, Segment Forecast With Teva Pharmaceutical, GlaxoSmithKline, Adamas Pharmaceuticals, Immutep, Novartis, AbbVie, Acorda Therapeutics, Amneal Pharmaceuticals, Imugene Limited, Osmotica Pharmaceuticals, Vertical Pharmaceu

06-04-2019 02:27 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Parkinson’s Disease Market

Parkinson’s Disease Market

The parkinson’s disease market report serves with all-inclusive, highly-effective, and thoroughly analyzed information in a well-organized manner, based on actual facts, about the Market. The whole information from the scratch to the financial and management level of the established industries associated with the Market at the global level is initially acquired by the dedicated team. The gathered data in this parkinson’s disease report involves the information about the industry’s establishment, type and the form of products it manufactures, annual sales and revenue generation, the demand of the manufactured product in the market, marketing trends followed by the industry, and a lot more important information.

In this parkinson’s disease report, the market esteem is evaluated taking into consideration worldwide market of the overall industry and noteworthy fragments, notwithstanding that the application, alongside size — Additionally, the conjecture for the item type and market portion are also been mentioned in this parkinson’s disease report. Various perspectives are dissected by the profiles of the players have been provided to offer a viewpoint of the market scene.

Global parkinson’s disease market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026. This significant rise in market value can increase research development initiatives to launching novel therapies.

To Get The Free Sample Of Report, Click On:

Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.

According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.

Key Market Players: Global Parkinson’s Disease Market

Few of the major competitors currently working in the global parkinson’s disease market are, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Acorda Therapeutics, Inc, Amneal Pharmaceuticals LLC , Imugene Limited, Immutep, F. Hoffmann-La Roche Ltd, Osmotica Pharmaceuticals plc, Vertical Pharmaceuticals, LLC, Adamas Pharmaceuticals, Inc, Novartis AG, Eli Lilly and Company, AbbVie Inc and few among others.

Market Drivers

· Increase in prevalence rate of parkinson’s disease worldwide

· Exposure to certain toxin or change in environment may increase the parkinson’s disease

· The launch of new products and research collaboration are the prime strategies to reinforce the market position

· Growing in aging population as it affect most commonly in geriatric population

· Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market

Market Restraints

· High cost involved in the treatment

· Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market

· Lack of awareness among the patient and physician about parkinson’s disease treatment

Access the TOC of the Parkinson’s Disease Market report:

Key Developments in the Market:

· In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients

· In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications

Segmentation: Global Parkinson’s Disease Market

By Type

· Drug-induced parkinsonism

· Vascular parkinsonism

· Normal pressure hydrocephalus (NSA)

· Corticobasal degeneration (CBD)

· Progressive supranuclear palsy (PSP)

· Multiple system atrophy (MSA)

· Idiopathic Parkinson’s

· Others

By Mechanism of Cation type

· Dopamine agonists

· Monoamine oxidase B (MAO-B) inhibitors

· Catechol-O-methyltransferase (COMT) inhibitors

· Adenosine A2 receptor antagonist

By Drug Type

· Amantadine

· Safinamide

· Brivaracetam

· Pimavanserin

· Carbidopa and levodopa

· Rivastigmine tartrate

· Rotigotine

· Ferampanel

· Apomorphine hydrochloride

· Pramipexole

· Others

By Therapy

· Medication

· Deep brain stimulation

· Others

By Route of administration

· Oral

· Parenteral

· Sublingual

· Others

By End Users

· Hospitals

· Homecare

· Specialty Clinics

· Others

By Geography

· North America

o U.S.

o Canada

o Mexico

· South America

o Brazil

o Argentina

o Rest of South America

· Europe

o Germany

o France

o United Kingdom

o Italy

o Spain

o Russia

o Turkey

o Belgium

o Netherlands

o Switzerland

o Rest of Europe

· Asia-Pacific

o Japan

o China

o South Korea

o India

o Australia

o Singapore

o Thailand

o Malaysia

o Indonesia

o Philippines

o Rest of Asia-Pacific

· Middle East & Africa

o South Africa

o Egypt

o Saudi Arabia

o United Arab Emirates

o Israel

o Rest of Middle East & Africa

Competitive Analysis: Global Parkinson’s Disease Market

Global parkinson’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of parkinson’s disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Want Full Report? Make Inquiries For Your Custom Requirements:

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinson’s Disease Market Insight, Segment Forecast With Teva Pharmaceutical, GlaxoSmithKline, Adamas Pharmaceuticals, Immutep, Novartis, AbbVie, Acorda Therapeutics, Amneal Pharmaceuticals, Imugene Limited, Osmotica Pharmaceuticals, Vertical Pharmaceu here

News-ID: 1764254 • Views: 165

More Releases from Data Bridge Market Research

Best Global Polymer Chameleon Market Tips to boost the Business
Global Polymer Chameleon Market By Product (Thermo-Responsive polymers, Photo-Responsive Polymers, Shape Memory Polymers, Electroactive & Magnetically-Responsive Polymers, pH-Responsive Polymers, Enzyme-Responsive Polymers, Self-Healing Polymers, Others), Application (Smart Drug Delivery System & Implants, Bioseparation, Textile engineering, Automotive & transportation, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand,
Global Catalytic Converter Market In Depth SWOT Analysis and Market Forecast !!
A new Global Catalytic Converter market research report has been added to the repository of Data Bridge Market Research which aims to give a complete overview of the Global Catalytic Converter market. This report has been designed with purpose of enlightening the readers with deep market insights such as its definition, share, trends, volume and demand/supply. It considers different key players prevailing in the market and evaluates different socio-economic, political
Uninterruptible Power Supply (UPS) Market 2020 In depth Studies with Top Vendors …
The Global Uninterruptible Power Supply (Ups) Industry: 2020 Market Report is a professional and in-depth study on the current state of the Uninterruptible Power Supply (Ups) Market. The report describes in-depth and comprehensive market study along with current and forthcoming opportunities that emphasizes the future market investment. It becomes simple to illustrate the commerce strategies for the businesses of small, medium as well as large size with the help of
Global Proctitis Market 2020:Growth Analysis By Sun Pharmaceuticals industries L …
Proctitis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the inflammatory diseases worldwide and emerging markets are the factors responsible for the growth of this market. The Proctitis market research report provides a unique guidance in providing thoughtful details regarding the development

All 5 Releases

More Releases for Parkinson’s

Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial